Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Genetron Holdings Limited Sponsored ADR (GTH : NSDQ)
 
 • Company Description   
Genetron Holdings Limited provides precision oncology platform principally in China. It specializes in cancer molecular profiling and harnesses advanced technologies in molecular biology and data science to transform cancer treatment. The Company's product and service portfolio cover the full-cycle of cancer care from early screening, to diagnosis and treatment recommendations, to continuous monitoring and continuous care. Genetron Holdings Limited is based in BEIJING, China.

Number of Employees: 799

 
 • Price / Volume Information   
Yesterday's Closing Price: $1.38 Daily Weekly Monthly
20 Day Moving Average: 237,221 shares
Shares Outstanding: 90.60 (millions)
Market Capitalization: $125.03 (millions)
Beta: 1.22
52 Week High: $23.37
52 Week Low: $1.25
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -32.68% -26.29%
12 Week -59.65% -54.65%
Year To Date -77.38% -72.36%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
1-2/F BUILDING 11 ZONE 1 CHANGPING DISTRICT
-
BEIJING,F4 102206
CHN
ph: 86-10-5090-7500
fax: -
ir@genetronhealth.com http://www.genetronhealth.com
 
 • General Corporate Information   
Officers
Sizhen Wang - Chief Executive Officer and Director
Weiwu He - Chairman of the Board of the Directors
Evan Ce Xu - Chief Financial Officer
Xia Wu - Director
Weidong Liu - Director

Peer Information
Genetron Holdings Limited Sponsored ADR (CORR.)
Genetron Holdings Limited Sponsored ADR (RSPI)
Genetron Holdings Limited Sponsored ADR (CGXP)
Genetron Holdings Limited Sponsored ADR (BGEN)
Genetron Holdings Limited Sponsored ADR (GTBP)
Genetron Holdings Limited Sponsored ADR (RGRX)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-BIOMED/GENE
Sector: Medical
CUSIP: 37186H100
SIC: 8071
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 12/01/21
Next Expected EPS Date: 05/23/22
Share - Related Items
Shares Outstanding: 90.60
Most Recent Split Date: (:1)
Beta: 1.22
Market Capitalization: $125.03 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 05/23/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 0.65
Price/Cash Flow: -
Price / Sales: 1.51
EPS Growth
vs. Year Ago Period: -133.33%
vs. Previous Quarter: -27.27%
Sales Growth
vs. Year Ago Period: 12.27%
vs. Previous Quarter: -2.65%
ROE
03/31/22 - -
12/31/21 - -34.68
09/30/21 - -25.57
ROA
03/31/22 - -
12/31/21 - -29.00
09/30/21 - -21.86
Current Ratio
03/31/22 - -
12/31/21 - 4.70
09/30/21 - -
Quick Ratio
03/31/22 - -
12/31/21 - 4.57
09/30/21 - -
Operating Margin
03/31/22 - -
12/31/21 - -93.27
09/30/21 - -78.32
Net Margin
03/31/22 - -
12/31/21 - -93.27
09/30/21 - -78.32
Pre-Tax Margin
03/31/22 - -
12/31/21 - -94.48
09/30/21 - -
Book Value
03/31/22 - -
12/31/21 - 2.14
09/30/21 - -
Inventory Turnover
03/31/22 - -
12/31/21 - 6.23
09/30/21 - -
Debt-to-Equity
03/31/22 - -
12/31/21 - 0.00
09/30/21 - -
Debt-to-Capital
03/31/22 - -
12/31/21 - 0.00
09/30/21 - -
 

Powered by Zacks Investment Research ©